+
Site Tour

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

MitraClip™ TEER is safe and effective across all age groups, including the very elderly. Next-generation devices provide consistent benefits in MR reduction, LV remodeling, and quality of life, regardless of age.

Download

LEARN MORE:

EuroPCR Symposium 2025 MitraClip

Related Resources

bRIGHT 2-year real-world outcomes

Prognosis of TR after MitraClip for MR

TRILUMINATE Pivotal - 2-year update EuroPCR 25

Epic Mitral – 10-Year Clinical Outcomes

Navitor Valve in small aortic annuli

Data Summary PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ Live-in-a-box

PCR LV 2021: Navitor™ 30-day outcomes

TRENDING TOPICS

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 25, presented by G. Singh

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

bRIGHT 2-year real-world outcomes

bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian

CONNEXT


TV
RELATED RESOURCES

Tendyne™: Animation

Navitor™: Voice of the Experts Maurizio Taramasso

TAVI 2023: Optimizing TAVI

Case Parade | Mitral focus

CONNEXT


LIVE
RELATED EVENTS

Screening Transmission | Mitral focus

TAVI Summit - Cardiac imaging

TAVI Summit 2023: Streamline implantation

TAVI Summit - Live case from Berlin

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline